Showing results (241-250 of 330) with videos related to

Sort By:
Pageof 33
Oncotarget|August 16, 2019
Tumor-associated macrophages and individual chemo-susceptibility are influenced by iron chelation in human slice cultures of gastric cancerSebastian Prill, Jakob Rebstock, Anja Tennemann, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2015
Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische OnkologieSylvie Lorenzen, Jorge Riera Knorrenschild, Georg-Martin Haag, et al.
Cancer Treatment Reviews|November 4, 2025
Evolving treatment strategies for resectable gastric cancer: Bridging Asia-West disparities toward personalized and integrated therapyXuesong Zhao, Qianyun Hao, Maria Alsina, et al.
Cancer Medicine|April 14, 2016
Organotypic slice cultures of human gastric and esophagogastric junction cancerJustus Koerfer, Sonja Kallendrusch, Felicitas Merz, et al.
BMC Cancer|December 14, 2011
Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO)Birgit Luber, Joëlle Deplazes, Gisela Keller, et al.
Journal of Cancer Research and Clinical Oncology|March 13, 2017
HER2 testing in gastric cancer: results of a German expert meetingFlorian Lordick, Salah-Eddin Al-Batran, Manfred Dietel, et al.
JAMA Network Open|February 16, 2023
Validation of the ONKOTEV Risk Prediction Model for Venous Thromboembolism in Outpatients With CancerChiara A Cella, Maren Knoedler, Marcia Hall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2006
Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancerClaus Rödel, Torsten Liersch, Robert Michael Hermann, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2018
Perioperative chemotherapy with or without epidermal growth factor receptor blockade in unselected patients with locally advanced oesophagogastric adenocarcinoma: Randomized phase II study with advanced biomarker program of the German Cancer Society (AIO/CAO STO-0801)Michael Stahl, Annett Maderer, Florian Lordick, et al.
The Oncologist|November 8, 2025
Fertility preservation practices and gastrointestinal oncologist in Europe: a pan-European studyIrit Ben-Aharon, Tal Goshen-Lago, Alberto Puccini, et al.
Pageof 33